Loading Events

« All Events

RARE Partnering & Investor Forum

September 14

THE FIRST-EVER RARE DISEASE PARTNERING EVENT WHERE SCIENCE INNOVATORS AND INVESTORS CONVERGE

Early Bird Registration Pricing Ends July 31st

EBD Group’s 1:1 Partnering Platform * Panel Discussions with Industry Experts * Company Presentations * ‘Shark Tank’-Style Pitch Competition Featuring Promising Early Stage Companies

Participating Partners and Investors (to date):
John Crowley, Chairman and CEO, Amicus Therapeutics
Brad Margus, Founder & CEO, Cerevance
Bharatt Chowrira, President & Chief of Business & Strategy, PureTech Health
Camille Samuels, Managing Partner, Venrock
Neil Kumar, CEO, BridgeBio
Alison Silva, CEO & President
Critical Outcome Technologies Inc., The Orphan Group
Michael Pistone, Strategic Marketing & Business Development, Cincinnati Children’s Hospital
Matthew Howes, EVP, Strategy & Growth, Palio
Jeremy Springhorn, Flagship Pioneering
Ashish Sagrolikare, Office of Commercial Transformation, GSK
Art Pappas, Managing Partner, Pappas Capital
Vern Norviel, Partner, Wilson Sonsini Goodrich & Rosati
Kush Parmar, MD, Ph.D., Managing Partner, 5AM Ventures
Michael Broxson, VP, Manager Business Development, Takeda Pharmaceuticals

Innovators and Investors will converge at RARE Partnering, an event not to be miss​ed. #2017GGForum.

For more information on partnering, email Nicoleb@globalgenes.org.

Thank you to our Sponsors:
Shire
Cincinnati Children’s, EBD Group, Horizon Pharma, Retrophin, The Scientist, Ultragenyx Pharmaceutical, inVentiv Health

And Partners:
Alliance for Regenerative Medicine, Cerevance, CLSA, Critical Outcome Technologies Inc.

MORE INFORMATION

Details

Date:
September 14
Event Categories:
,

Venue

Hotel Irvine
17900 Jamboree Road
Irvine , CA 92614 United States
+ Google Map